Matilde Pensabene

1.2k total citations
35 papers, 597 citations indexed

About

Matilde Pensabene is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Matilde Pensabene has authored 35 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Matilde Pensabene's work include BRCA gene mutations in cancer (16 papers), Genetic factors in colorectal cancer (6 papers) and Breast Cancer Treatment Studies (5 papers). Matilde Pensabene is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Genetic factors in colorectal cancer (6 papers) and Breast Cancer Treatment Studies (5 papers). Matilde Pensabene collaborates with scholars based in Italy, United States and France. Matilde Pensabene's co-authors include Michelino De Laurentiis, Sabino De Placido, Francesco Nuzzo, Germira Di Gioia, Michela Piezzo, Daniela Cianniello, Vincenzo Di Lauro, Roberta Caputo, Giuseppina Fusco and Stefania Cocco and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Matilde Pensabene

33 papers receiving 580 citations

Peers

Matilde Pensabene

ONCOL

PRM

GENET

Domenico Sergi Italy

Zora Nešković‐Konstantinović Serbia

Fernando Lara-Medina Mexico

Luis T. Campos United States

Ida Paris Italy

Hongjian Yang China

A. Goldhirsch Italy

Tallal Younis Canada

E. E. Holdener Switzerland

Parvin F. Peddi United States

Domenico Sergi Italy

Matilde Pensabene

359 ×1.5

ONCOL

166 ×0.9

PRM

178 ×1.0

96 ×0.6

GENET

157 ×1.1

Citations per year, relative to Matilde Pensabene Matilde Pensabene (= 1×) peers Domenico Sergi

Countries citing papers authored by Matilde Pensabene

Since Specialization

Citations

This map shows the geographic impact of Matilde Pensabene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Pensabene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Pensabene more than expected).

Fields of papers citing papers by Matilde Pensabene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilde Pensabene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Pensabene. The network helps show where Matilde Pensabene may publish in the future.

Co-authorship network of co-authors of Matilde Pensabene

This figure shows the co-authorship network connecting the top 25 collaborators of Matilde Pensabene. A scholar is included among the top collaborators of Matilde Pensabene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilde Pensabene. Matilde Pensabene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calabrese, Alessandra, et al.. (2024). Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes. Cancer Treatment Reviews. 129. 102785–102785. 7 indexed citations

Pensabene, Matilde, Alessandra Calabrese, Claudia von Arx, R. Caputo, & Michelino De Laurentiis. (2024). Cancer genetic counselling for hereditary breast cancer in the era of precision oncology. Cancer Treatment Reviews. 125. 102702–102702. 4 indexed citations

Guerrieri‐Gonzaga, Aliana, Davide Serrano, Patrizia Gnagnarella, et al.. (2024). Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer. PLoS ONE. 19(9). e0309511–e0309511. 1 indexed citations

Caputo, Roberta, et al.. (2023). Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report. Frontiers in Oncology. 13. 1214660–1214660.

Nunziato, Marcella, Federica Di Maggio, Matilde Pensabene, et al.. (2022). Multi-gene panel testing increases germline predisposing mutations’ detection in a cohort of breast/ovarian cancer patients from Southern Italy. Frontiers in Medicine. 9. 894358–894358. 13 indexed citations

Piezzo, Michela, Stefania Cocco, Roberta Caputo, et al.. (2020). Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors. International Journal of Molecular Sciences. 21(18). 6479–6479. 126 indexed citations

Buono, Giuseppe, Mario Giuliano, Carmine De Angelis, et al.. (2017). Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study. Clinical Breast Cancer. 17(7). 559–563. 12 indexed citations

Arpino, Grazia, Matilde Pensabene, I. Cerillo, et al.. (2016). Tumor characteristics and prognosis in familial breast cancer. BMC Cancer. 16(1). 924–924. 22 indexed citations

Gargiulo, Piera, Matilde Pensabene, Monica Milano, et al.. (2016). Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC Cancer. 16(1). 375–375. 32 indexed citations

10.

Podo, Franca, Filippo Santoro, Giovanni Di Leo, et al.. (2015). Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study. Clinical Cancer Research. 22(4). 895–904. 24 indexed citations

11.

Fabbrocini, Gabriella, Luigia Panariello, Matilde Pensabene, et al.. (2013). EMPACT Syndrome Associated with Phenobarbital. Dermatitis. 24(1). 37–39. 5 indexed citations

12.

Pepe, Stefano, et al.. (2012). Modifiers of Risk in BRCA1/2 Mutation Carriers. Current Women s Health Reviews. 8(1). 23–29. 2 indexed citations

13.

Pensabene, Matilde, Stefano Pepe, Alma Contegiacomo, et al.. (2009). Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Annals of Oncology. 20(5). 874–878. 18 indexed citations

14.

Marroni, Fabio, Giovanna Cipollini, Bernard Peissel, et al.. (2008). Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis. Annals of Human Genetics. 72(3). 310–318. 16 indexed citations

15.

Tauchmanovà, Libuse, Matilde Pensabene, Pio Zeppa, et al.. (2005). Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR. Journal of Endocrinological Investigation. 28(6). 371–378. 2 indexed citations

16.

Contegiacomo, Alma, Matilde Pensabene, Libuse Tauchmanovà, et al.. (2004). An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Annals of Oncology. 15(5). 726–732. 25 indexed citations

17.

Ottaiano, Alessandro, Ernesto Mollo, Giuseppe Di Lorenzo, et al.. (2004). Prospective clinical trials of biotherapies in solid tumors: a 5-year survey. Cancer Immunology Immunotherapy. 54(1). 44–50. 8 indexed citations

18.

Perrone, Francesco, Massimo Di Maïo, Ermelinda De Maio, et al.. (2003). Statistical design in phase II clinical trials and its application in breast cancer. The Lancet Oncology. 4(5). 305–311. 17 indexed citations

19.

Tortora, Giampaolo, Fortunato Ciardiello, V. Damiano, et al.. (2002). Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer. Annals of Oncology. 13(3). 392–398. 12 indexed citations

20.

Ricchi, Paolo, Tiziana Di Matola, Giuseppina Ruggiero, et al.. (2002). Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs. British Journal of Cancer. 86(9). 1501–1509. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact